News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Earnings (World)
Cannimed Reports Financial Results For 2016 2/24/2017
Galapagos (GLPG.BR) Reports Strong Financial Results And Newsflow-Rich Pipeline 2/24/2017
China Biologic Products Reports Financial Results For The Fourth Quarter And Fiscal Year 2016 2/24/2017
Karolinska Development AB - Q4 And 2016 Year-End Report - Invitation To Conference Call And Webcast 2/24/2017
NovoCure Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Company Update 2/23/2017
Ipsen (IPN.PA) Delivers Strong 2016 Results And Expects Further Sales Growth And Margin Enhancement For 2017 2/23/2017
Recipharm AB Release: Full Year Report January - December 2016 2/23/2017
Bluechiip Ltd Half Yearly Report And Accounts 2/23/2017
OncoGenex (OGXI) Reports Financial Results For Year End 2016 2/23/2017
Genmab A/S (GEN.CO) 2016 Annual Report 2/23/2017
CRH Medical Announces 2016 Fourth Quarter And Year-End Results 2/23/2017
Nordic Nanovector: Invitation To Fourth Quarter And Full Year 2016 Results Presentation And Webcast 2/22/2017
Wright Medical Group (WMGI) Reports 2016 Fourth Quarter And Full-Year Financial Results And Provides 2017 Guidance 2/22/2017
Foamix Pharma (FOMX) Reports Year End 2016 Financial Results And Provides Business Update 2/22/2017
Confident Medtronic (MDT)'s Q3 Beats Expectations 2/21/2017
NeuroVive (NVP) Year End Report January - December 2016 2/21/2017
Vernalis PLC (VNLPY.PK): Unaudited Interim Results For The Six Months Ended 31 December 2016 2/21/2017
Invitation To Presentation Of Recipharm AB’s Full Year Report For 2016 On The 23rd February 2/20/2017
ICON Reports Fourth Quarter And Full Year 2016 Results 2/16/2017
Teva (TEVA) Has Really Bottomed Out This Time 2/16/2017
Shire (SHPG) Reports Full Year 2016 Results With Record Revenue; Positioned For Continued Strong Growth Driven By Best-In-Class Rare Disease Pipeline 2/16/2017
Gerresheimer Delivers Sustained Profitability Growth In 2016 And Proposes A Dividend Increase Of 23.5% 2/16/2017
Alkermes (ALKS) Reports Financial Results For The Year Ended Dec. 31, 2016 And Provides Financial Expectations For 2017 2/15/2017
BioInvent (BOVNF) Financial Statement 1 January – 31 December 2016 2/15/2017
China Biologic Products To Report Fourth Quarter And Fiscal Year 2016 Financial Results 2/15/2017
Jazz Pharma (JAZZ) To Report 2016 Fourth Quarter And Full Year Financial Results On February 28, 2017 2/15/2017
Axovant (AXON) Announces Dementia Pipeline Updates And Reports Financial Results For The Third Fiscal Quarter And Nine Months Ended December 31, 2016 2/15/2017
ScinoPharm Reports Financial Performance For 2016 2/15/2017
Alcobra (ADHD) Announces Fourth-Quarter And Full-Year 2016 Financial Results And Provides Corporate Update 2/15/2017
Compugen Ltd. (CGEN) Reports Fourth Quarter And Calendar Year 2016 Results 2/15/2017
Theravance (THRX) To Report Fourth Quarter And Full Year 2016 Financial Results On February 27, 2017 2/15/2017
Guerbet (GBT): 2016 Revenue 2/15/2017
Perrigo (PRGO) To Release Fourth Quarter And Calendar Year 2016 Results On February 27, 2017 2/14/2017
Avadel Pharma (FLML) To Report Fourth Quarter And Full Year 2016 Results 2/14/2017
Carmat (ALCAR.PA) Release: 2016 Annual Results 2/14/2017
Teva (TEVA) Reports Full Year And Fourth Quarter 2016 Financial Results 2/13/2017
Recordati: Preliminary 2016 Results Confirm Continued Growth Of Revenues And Profitability. New Three Year Business Plan Presented 2/9/2017
Unlike Many of Its Peers, Allergan (AGN) Beats Forecast and Is on the Hunt for More M&A Deals 2/9/2017
Zealand Pharma  (ZEAL.CO) Reports Q4 2016 Lyxumia Royalty Revenue 2/8/2017
Sanofi (SNY) Delivers 2016 Sales And Business EPS(1) Growth At CER(2) 2/8/2017
Foamix Pharma (FOMX) To Release Fiscal Year 2016 Financial Results And Host Conference Call & Webcast On Wednesday, February 22 2/8/2017
Quartesian Posts Record Results For 2016 As Trusted Clinical Data Management Partner 2/8/2017
Sanofi (SNY) Delivers 2016 Sales And Business EPS Growth At CER 2/8/2017
Mallinckrodt (MNK) Reports Transition Period Results And Announces 2017 Guidance 2/7/2017
GW Pharma (GWPH) Reports First Quarter 2017 Financial Results And Operational Progress 2/7/2017
Dr. Reddy's Laboratories, Inc. (RDY)’s Q3 And 9M FY17 Financial Results 2/6/2017
QIAGEN N.V. (QGEN) Reports Results For Fourth Quarter And Full-Year 2016 2/6/2017
Sobi - Invitation - Presentation Of Sobi's Q4 And FY 2016 Results 2/6/2017
Kamada Ltd. (KMDA) Reports Financial Results For The Fourth Quarter And Full-Year 2016 2/6/2017
Hutchison China MediTech (Chi-Med) To Announce 2016 Final Results 2/6/2017
Genmab A/S (GEN.CO) Announces Updated 2016 Financial Guidance 2/6/2017
Allergan (AGN) Declares First Quarterly Cash Dividend Of $0.70 Per Ordinary Share 2/3/2017
Teva (TEVA) To Report Fourth Quarter 2016 Financial Results On February 13, 2017 2/2/2017
Are Teva (TEVA)'s Best Days Behind It? 2/2/2017
Kamada Ltd. (KMDA) To Host Fiscal Year 2016 Financial Results Conference Call On February 6 2/2/2017
MMJ PhytoTech Quarterly Update 2/1/2017
Takeda (TKPYY) Reports Q3 FY2016 Results And Improves Year-End Outlook 2/1/2017
Wright Medical Group (WMGI) To Host Fourth Quarter 2016 Earnings Conference Call 1/31/2017
Compugen Ltd. (CGEN) Fourth Quarter And Yearend 2016 Conference Call Scheduled For Wednesday, February 15, 2017 At 10:00 AM EST 1/31/2017
Astellas (ALPMY) Reports The First Nine Months Financial Results Of FY2016 1/31/2017
Hoya Announces Third Quarter Financial Results 1/31/2017
GW Pharma (GWPH) To Report Q1 Financial Results And Host Conference Call On 7 February, 2017 1/30/2017
Vexim: Amendment Of The Financial Agenda For 2017 1/30/2017
Sartorius Corporation Grows By Double Digits In Sales Revenue And Earnings In 2016 – Positive Outlook For 2017 1/30/2017
Vernalis PLC (VNLPY.PK): Notice Of Results For Six Months Ended 31/12/2016 1/30/2017
Orexo (ORXOF) - Full Year Report 2016 1/26/2017
Angle: Interim Results For The Six Months Ended 31 October 2016 1/26/2017
Getinge Year-End Report January-December 2016 1/26/2017
LivaNova PLC (LIVN) Release: Company To Host Conference Call For Fourth Quarter 2016 Results 1/25/2017
Bluechiip Ltd Release: Company December 2016 Quarterly Cash Flow Report 1/25/2017
Clinigen Release: HY Trading Update: Strong H1 Performance With Gross Profit Up 34% 1/25/2017
Lonza Group (LZAGY.PK) Release: Company Reports Record-Breaking Financial Performance, Resulting In 24.2% CORE EBIT Growth, Driven By Pharma&Biotech 1/25/2017
Vectura (VEC.L) Release: Seebri / Ultibro Breezhaler 2016 Sales Reach $512 Million Triggering $5 Million Milestone Receipt 1/25/2017
Board of Scientific Digital Imaging plc Release: Unaudited Interim Results For The Six Months To 31 October 2015 1/24/2017
NOVACYT Release: Company Revenues Full Year 2016 1/24/2017
Dr. Reddy's Laboratories Ltd. (RDY) Release: Company To Release Q3 FY17 Results On Feb 4, 2017 1/23/2017
Novozymes (NVZMY) Release: Company Reports 6% Organic Sales Growth In Q4 1/19/2017
Safe Orthopaedics, SA Release: Company Reports Revenue Growth Of 10% In FY 2016*, With An Acceleration In The Fourth Quarter 1/19/2017
QIAGEN N.V. (QGEN) Release: Company To Report Fourth Quarter And Full Year Of 2016 Results 1/18/2017
Vexim Release: Company Sets New Sales Record In The 4th Quarter 2016 And Solidifies Its Position As A Major Player In Spine Trauma 1/17/2017
Allergan (AGN) Release: Company To Report Fourth Quarter And Full Year 2016 Earnings And Host Conference Call And Webcast 1/12/2017
MEDICREA Release: Company Announces Financial Calendar For 2017 1/12/2017
Quest Diagnostics (DGX) Release: Company To Release Fourth Quarter And Full Year 2016 Financial Results On January 26 1/11/2017
ICON Release: Pharma Issues Financial Guidance For Full Year 2017 1/10/2017
Genomic Vision Doubles Its Installed Base Of Fibervision Platforms And Quadruples Its Sales Of Products And Services In 2016 1/9/2017
C4X Discovery Full Year Results For The Year Ended 31 July 2016 1/6/2017
InMed Provides 2016 Year End Update 12/27/2016
AorTech International plc Shares Fall 19% As Revenue Dips 12/21/2016
Genmab A/S (GEN.CO) Announces Submission Of Regulatory Application For Daratumumab In Relapsed/Refractory Multiple Myeloma In Japan And Updates Financial Guidance 12/20/2016
SQI Diagnostics Reports Fourth Quarter And Fiscal 2016 Results 12/7/2016
GW Pharma (GWPH) Reports Fourth Quarter And Year-End 2016 Financial Results And Operational Progress 12/5/2016
GW Pharma (GWPH) To Report Q4 And Year-End Financial Results And Host Conference Call On 5 December, 2016 12/1/2016
Ascendis Reports Third Quarter 2016 Financial Results 12/1/2016
Antibe Therapeutics (ATE.V) Reports Q2 2017 Interim Financial And Operating Results 11/30/2016
Mallinckrodt (MNK) Reports Fiscal 2016 Fourth Quarter And Full-Year Results 11/29/2016
Advanced Accelerator Applications Reports 15.4% Sales Growth In The Third Quarter Of 2016 And Feedback From The FDA For Lutathera, An Investigational Treatment For Neuroendocrine Tumors 11/28/2016
Can-Fite BioPharma (CFBI) Reports Financial Results For Nine Months Ended September 30, 2016 & Provides Clinical Update 11/28/2016
Sinovac Biotech Ltd. (SVA) Reports Unaudited Third Quarter 2016 Financial Results 11/28/2016
BiondVax Pharmaceuticals Announces Third Quarter 2016 Financial Results And Update 11/28/2016
Wilson Therapeutics Interim Report January 1 – September 30, 2016 11/28/2016
Advanced Accelerator Applications To Announce Third Quarter And Nine-Month 2016 Financial Results On November 28 11/23/2016
Golden Meditech Announces FY2016/2017 Interim Results 11/23/2016
Karolinska Development AB: Interim Report For January-September 2016 11/23/2016
Nordic Nanovector– Results For Third Quarter 2016 11/23/2016
Innocoll (INNL) Announces Third Quarter 2016 Financial And Operating Results And Provides Corporate Update 11/22/2016
Biostar Pharmaceuticals, Inc. (BSPM) Announces Its Quarterly Results for Three Months Ended September 30, 2016 11/22/2016
BioLineRx Reports Third Quarter 2016 Financial Results 11/22/2016
Oxford Gene Technology Ltd. Announces Commercial and Financial Highlights For FY 2016 11/22/2016
NeuroVive (NVP) Interim Report January - September 2016 11/22/2016
China Cord Blood Reports Financial Results For The Second Quarter And First Half Of Fiscal 2017 11/18/2016
Tikcro Technologies Reports Third Quarter 2016 Results 11/18/2016
Karolinska Development AB – Q3 2016 Interim Report - Invitation To Conference Call And Webcast 11/17/2016
Nabriva Reports Third Quarter 2016 Financial Results 11/16/2016
Innocoll (INNL) To Report Third Quarter 2016 Financial Results And Host Webcast And Conference Call On November 22, 2016 11/15/2016
Neovasc (NVC) Reports Third Quarter Results For 2016 11/15/2016
Alcobra (ADHD) Announces Third Quarter 2016 Financial Results And Provides Corporate Update 11/15/2016
China Pharma Holdings (CPHI.OB) Reports Third Quarter Financial Results 11/15/2016
Sinovac Biotech Ltd. (SVA) To Host Conference Call To Report Third Quarter 2016 Unaudited Financial Results 11/15/2016
BrainStorm Cell Reports Third Quarter 2016 Financial Results 11/15/2016
ProMetic Life Sci (PFSCF.PK) Reports Third Quarter 2016 Highlights And Financial Results 11/15/2016
BioLineRx To Report Third Quarter Results On November 22, 2016 11/15/2016
Teva (TEVA) Reports Third Quarter 2016 Results 11/15/2016
OncoGenex (OGXI) Reports Financial Results For Third Quarter 2016 11/14/2016
SciBase AB: Interim Report 11/14/2016
Perrigo (PRGO) Reports Third Quarter 2016 Financial Results 11/11/2016
Medicure (MCU) Reports Third Quarter 2016 Financial Results 11/11/2016
Adaptimmune (ADAP) Reports Third Quarter 2016 Financial Results 11/10/2016
NeuroDerm (NDRM) Announces Third Quarter 2016 Financial Results 11/10/2016
Recipharm AB Release: Interim Report January-September 2016 11/10/2016
Biotage AB (BIOTa.ST): Interim Report January-September 2016 11/10/2016
Bactiguard AB: Interim Report For Q3 2016 11/10/2016
Evotec AG (EVTG.F) Reports Results Of First Nine Months Of 2016 11/10/2016
Mylan (MYL) Reports Third Quarter 2016 Results 11/10/2016
Epigenomics AG Announces 2016 Third Quarter And Nine Months Financial Results And Reports On Operational Highlights 11/9/2016
Hansa Medical Interim Report July – September 2016 11/9/2016
Axovant (AXON) Announces Dementia Pipeline Updates And Reports Financial Results For The Second Fiscal Quarter And First Half Ended September 30, 2016 11/9/2016
Endo International (ENDP) Reports Third Quarter 2016 Financial Results 11/9/2016
Jazz Pharma (JAZZ) Announces Third Quarter 2016 Financial Results 11/9/2016
GENFIT (ALGFT): Third Quarter 2016 Financial Information 11/8/2016
Galmed Pharmaceuticals Reports Third Quarter 2016 Financial Results And Provides Business Update 11/8/2016
Bone Therapeutics Taps a New CEO, Drops Plan to Initiate Cell Therapy Trial in the U.S. 11/8/2016
Merus (MRUS) Announces Third Quarter 2016 Financial Results And Corporate Developments 11/7/2016
Horizon Pharma (HZNP) Announces Third-Quarter 2016 Financial Results 11/7/2016
Compugen Ltd. (CGEN) Reports 3rd Quarter 2016 Financial Results 11/7/2016
Flamel Technologies (FLML) Reports Third Quarter 2016 Results 11/7/2016
BioAmber Reports Third Quarter 2016 Financial And Operational Results 11/4/2016
Nexvet Reports Financial Results For First Quarter Of Fiscal Year 2017 11/4/2016
Auris Med (EARS) To Announce Third Quarter 2016 Financial Results And Host Conference Call On Thursday, November 10, 2016 11/4/2016
N1 Technologies Posts Strong 3Q Results 11/4/2016
ERYtech Pharma Provides Business Update And Reports Financial Highlights For Third Quarter 2016 11/4/2016
Kamada Ltd. (KMDA) To Host Third Quarter Financial Results Conference Call On November 10, 2016 At 8:30 Am Eastern Time 11/3/2016
China Biologic Products Reports Financial Results For The Third Quarter Of 2016 11/3/2016
QIAGEN N.V. (QGEN) Reports Results For Third Quarter And First Nine Months Of 2016 11/3/2016
Genmab A/S (GEN.CO) Announces Financial Results For The First Nine Months Of 2016 And Improves 2016 Financial Guidance 11/3/2016
Evotec AG (EVTG.F) To Report First Nine-Month 2016 Results On 10 November 2016 11/3/2016
In 3Q Report, Shire (SHPG) Breaks Out Data From Baxalta (BXLT) Acquisition and Announces Several Program Terminations 11/2/2016
Mauna Kea Technologies Reports Third Quarter 2016 Sales 11/2/2016
Theravance (THRX) To Report Third Quarter 2016 Financial Results On November 8, 2016 11/2/2016
Bone Therapeutics Notice Of Q3 2016 Results 11/2/2016
Acerus (TRLPF) Reports Third Quarter 2016 Financial Results 11/2/2016
Alkermes (ALKS) Reports Third Quarter 2016 Financial Results 11/2/2016
MMJ PhytoTech Quarterly Update And Appendix 4C 11/1/2016
Cardiome Pharma Corp. (COM.TO) To Reschedule Release Of Third Quarter 2016 Financial Results 11/1/2016
Oxford Immunotec (OXFD) Reports Third Quarter 2016 Financial Results 11/1/2016
Alcobra (ADHD) To Release Third Quarter Financial Results And Host Corporate Update Conference Call & Webcast On November 15 11/1/2016
NeuroDerm (NDRM) To Host Third Quarter 2016 Financial Results Conference Call On November 10, 2016 11/1/2016
Quotient Limited (QTNTU) Reports Continued Progress On The Commercial Scale-Up Of Mosaiq™ And Second Quarter Fiscal 2017 Financial Results 11/1/2016
Helix Biopharma (TSX:HBP) Announces Fiscal 2016 Results 11/1/2016
NOXXON Pharma AG Releases Its Interim 2016 Results 10/31/2016
Galapagos (GLPG.BR) Release: Robust Progress In Q3 2016 10/28/2016
Sanofi (SNY) Announces Strong Q3 2016 Results 10/28/2016
Takeda (TKPYY) Reports First Half FY2016 Results And Raises Full Year Profit Guidance 10/28/2016
Hanmi Pharma (128940.KS)’s Q3 Operating Profit Plunges 62% 10/27/2016
Concordia (CXR.TO) Announces Release Date For Third Quarter 2016 Results 10/27/2016
Alkermes (ALKS) To Host Conference Call To Discuss Third Quarter 2016 Financial Results 10/27/2016
Karo Pharma: Interim Report January – September 2016 10/27/2016
Swedish Orphan Biovitrum AB: Sobi Publishes Its Report For The Third Quarter 2016, Raises Guidance 10/27/2016
Lonza Group (LZAGY.PK) Expects To Reach 2018 Guidance One Year Ahead And Reports Strong Q3 Momentum 10/27/2016
Turning Around Novartis AG (NVS)'s Struggling Alcon (ACL) Unit Will Take Longer Than Expected 10/26/2016
Jazz Pharma (JAZZ) To Report 2016 Third Quarter Financial Results On November 8, 2016 10/26/2016
Flamel Technologies (FLML) To Report Third Quarter 2016 Results 10/26/2016
BioAmber Announces Webcast Of Fiscal Third Quarter 2016 Financial Results 10/25/2016
China Biologic Products To Report Third Quarter 2016 Financial Results 10/25/2016
Dr. Reddy's Laboratories Ltd. (RDY)’s Q2 And H1 FY17 Financial Results 10/25/2016
ICON Reports Third Quarter 2016 Results 10/20/2016
TRANSGENE (ENX:TNG) Reports Third Quarter 2016 Financial Results 10/20/2016
Orexo (ORXOF): Interim Report January-September 2016 10/20/2016
ThromboGenics NV (TBGNF) Business Update – Q3 2016 10/20/2016
Microbix Biosystems Inc. (MBXBF) Announces Preliminary Sales For 2016 10/19/2016
Valeant (VRX) Announces Third Quarter Financial Results Date And Conference Call Details 10/18/2016
Endo International (ENDP) To Announce Third Quarter 2016 Financial Results On November 8, 2016 10/18/2016
Quotient Limited (QTNTU) To Report Second Quarter Fiscal 2017 Financial Results And Host Conference Call 10/17/2016
Allergan (AGN) To Host Third Quarter 2016 Earnings Conference Call And Webcast 10/14/2016
Dr. Reddy's Laboratories Ltd. (RDY)'s To Release Q2 FY17 Results On Oct 25, 2016; Earnings Call Slated For Oct 25, 6.30 PM IST / 9.00 AM EDT 10/14/2016
Adocia Announces Third Quarter 2016 Financial Results 10/13/2016
Vexim Release: +37% Sales Increase To €13.3 Million As Of September 30, 2016 (9 Months) New Quarterly Sales Record 10/13/2016
Figures And Highlights 2015: Ascenion GmbH's Annual Report 10/12/2016
Compugen Ltd. (CGEN) Third Quarter Financial Statements To Be Released November 7, 2016 10/10/2016
MEDICREA Announces 2016 Third-Quarter Sales 10/7/2016
Veritas Pharma Inc Release: Cannevert Delivers Its Quarterly Research Report 10/6/2016



//-->